GlassScriptPhysician profile
Laura Halyk
NPI 1285466367
$1,905.40
in general payments reported to CMS, 2019-2025
12 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $236 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $560.45 | 2025 | Matriderm |
| Stryker Corporation | $330.47 | 2025 | Variax, Gamma, Conextions Tr Tendon Repair System-Implant Mechanism |
| Polynovo North America LLC | $202.75 | 2025 | Novosorb Btm |
| Axogen | $195.83 | 2024-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Tulavi Therapeutics, INC. | $195.70 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Checkpoint Surgical, INC | $145.78 | 2024 | Checkpoint Stimulators |
| Avita Medical Americas, LLC | $139.24 | 2025 | Cohealyx, Recell, Permeaderm |
| Urgo Medical North America, LLC | $34.72 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Endo USA, INC. | $29.37 | 2024 | Xiaflex |
| Solventum Corporation | $29.26 | 2024 | V.A.C.Instill |
| Pacira Pharmaceuticals Incorporated | $23.40 | 2025 | Exparel |
| Orthofix Medical, INC. | $18.43 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Halyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.